At The Leukemia & Lymphoma Society of Canada (LLSC) we're committed to funding research to help cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
When LLSC was founded in 1955, a diagnosis of leukemia, lymphoma, Hodgkin's disease or myeloma was almost always fatal. Today, thanks to innovative research funded in part by LLSC, survival rates for some blood cancers have doubled--and some have even tripled.
Current Research Funding in Canada
In 2016, we invested almost $6.5 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $3 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.5 million towards funding patient services, programs and education across Canada.
Our research track record demonstrates the depth of our commitment to our mission. What's more, many of the blood cancer treatment and therapies we've funded have gone on to benefit patients who have other types of cancer.
Click here to view our Research Program Highlights